Sigma-Aldrich settles with Enzo and Yale.
Under the agreement, Sigma-Aldrich will pay Enzo $2 million. The settlement will no doubt put pressure on the other defendants to also settle. The only defendant from which Enzo Biochem recorded revenues in fiscal year 2005 was PerkinElmer.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Executive Briefing: News, Trends & Market Intelligence for Instrument Executives|
|Publication:||Instrument Business Outlook|
|Date:||Sep 30, 2006|
|Previous Article:||Applied Biosystems and Promega settle legal disputes.|
|Next Article:||Private equity firm invests in lab supplier.|